Skip to main content
. Author manuscript; available in PMC: 2020 Jul 9.
Published before final editing as: Mult Scler. 2019 Jan 9:1352458518819608. doi: 10.1177/1352458518819608

Table 1.

Demographic, clinical, MRI and Doppler characteristics of the multiple sclerosis patients and the healthy controls.

Group characteristics MS (n=132) HC (n=47) p-value* Cohen’s d ANCOVA**
Female/male, n (females %) 92/40 (69.7) 34/13 (72.3) 0.761 - -
Age, mean (SD) 53.5 (11.3) 50.8 (12.8) 0.184 - -
Disease duration, mean (SD) 20.4 (10.5) - - - -
EDSS, median (IQR) 3.0 (2.0–6.0) - - - -
RRMS vs. PMS 82/50 - - - -
Body mass index, mean (SD) 27.7 (5.9) 26.4 (5.7) 0.230 - -
Hypertension, n (%) 25 (18.9) 12 (25.5) 0.402 - -
Hyperlipidemia, n (%) 27 (20.5) 11 (23.4) 0.681 - -
Heart Disease, n (%) 23 (17.4) 4 (8.5) 0.232 - -
Years of education, mean (SD) 14.9 (2.3) 14.7 (2.5) 0.639 - -
CVLT-II total, mean (SD) 51.9 (12.6) 54.9 (9.9) 0.107 0.262 0.222
BVMT-R total, mean (SD) 21.9 (7.9) 26.5 (6.5) 0.001 0.625 0.001
SDMT total, mean (SD) 49.5 (12.5) 55.5 (12.6) 0.013 0.442 0.029
Total CABF (ml/min) 961.6 (257.8) 967.5 (292.0) 0.897 0.026 0.822
T2-LV, mean (SD) 13.5 (16.0) 0.4 (1.1) <0.001 1.149 <0.001
GMV, mean (SD) 732.3 (60.5) 768.0 (58.1) 0.003 0.544 0.001

Legend: MS – multiple sclerosis, HC – healthy controls, IQR – interquartile range EDSS – Expanded Disability Status Scale, RRMS – relapsing-remitting multiple sclerosis, PMS – progressive multiple sclerosis, CVLT-II- California Verbal Learning Test - Second Edition, BVMT – Brief Visual-Spatial Memory Test, SDMT – Symbol Digit Modalities Test, CABF – cerebral arterial blood flow, GMV – gray matter volume, LV – lesion volume.

All neuropsychological test are shown as raw scores. P-values <0.05 was considered significant and are shown in bold.

*

χ2 test, Mann-Whitney ran-sum test and Student’s t-test were used, as appropriate.

**

Analysis of Covariance (ANCOVA) adjusted for age was used.